• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有阳性PLA2R标志物的原发性膜性肾病的管理与治疗

Management and Treatment of Primary Membranous Nephropathy With a Positive PLA2R Marker.

作者信息

Metuku Rajesh, Wynn Austin B, Santos Raul

机构信息

Research Department, Alabama College of Osteopathic Medicine, Dothan, USA.

Nephrology, Archbold Hospital, Alabama College of Osteopathic Medicine, Thomasville, USA.

出版信息

Cureus. 2024 Dec 3;16(12):e75057. doi: 10.7759/cureus.75057. eCollection 2024 Dec.

DOI:10.7759/cureus.75057
PMID:39759600
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11698536/
Abstract

Membranous nephropathy due to a positive PLA2R marker is an idiopathic cause of membrane nephropathy, characterized as an autoimmune attack on the kidney at the PLA2R receptor. Autoantibodies attack the PLA2R receptor, leading to nephrotic syndrome and eventually leading to end-stage renal failure, as in our case. We present a case that involves a patient who presented to the nephrology clinic with nephrotic range proteinuria and a history of HIV. The biopsy was prompted by nephrotic syndrome, where we saw clear evidence of sclerotic and fibrotic damage along with positive anti-PLA2R antibodies. The patient was put on tacrolimus and cyclophosphamide to halt the damage, but the patient eventually had to be put on dialysis later on. What makes this case unique is the patient is dealing with both the PLA2R antibodies and HIV, which increases the complexity of the treatment and our understanding of what played a bigger role in kidney failure. It is unique cases like these that prompt us to research further about these pathologies and develop new treatment options that result in a better prognosis.

摘要

磷脂酶A2受体(PLA2R)标志物阳性所致的膜性肾病是膜性肾病的一种特发性病因,其特征为在PLA2R受体处对肾脏发起自身免疫攻击。自身抗体攻击PLA2R受体,导致肾病综合征,并最终导致终末期肾衰竭,就像我们这个病例一样。我们报告一例患者,该患者因肾病范围蛋白尿前往肾病科就诊,并有HIV病史。肾病综合征促使进行活检,在此我们看到了硬化和纤维化损伤的明确证据以及抗PLA2R抗体阳性。该患者接受了他克莫司和环磷酰胺治疗以阻止损伤,但患者最终还是不得不接受透析治疗。该病例的独特之处在于患者同时患有PLA2R抗体和HIV,这增加了治疗的复杂性以及我们对肾衰竭中何种因素起更大作用的理解。正是像这样的独特病例促使我们进一步研究这些病理情况,并开发出能带来更好预后的新治疗方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d6e/11698536/a2166d4de599/cureus-0016-00000075057-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d6e/11698536/678ab8855312/cureus-0016-00000075057-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d6e/11698536/c5013c344e5c/cureus-0016-00000075057-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d6e/11698536/a2166d4de599/cureus-0016-00000075057-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d6e/11698536/678ab8855312/cureus-0016-00000075057-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d6e/11698536/c5013c344e5c/cureus-0016-00000075057-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d6e/11698536/a2166d4de599/cureus-0016-00000075057-i03.jpg

相似文献

1
Management and Treatment of Primary Membranous Nephropathy With a Positive PLA2R Marker.伴有阳性PLA2R标志物的原发性膜性肾病的管理与治疗
Cureus. 2024 Dec 3;16(12):e75057. doi: 10.7759/cureus.75057. eCollection 2024 Dec.
2
Primary Membranous Nephropathy.原发性膜性肾病
Clin J Am Soc Nephrol. 2017 Jun 7;12(6):983-997. doi: 10.2215/CJN.11761116. Epub 2017 May 26.
3
Clinical features, course and prognosis of idiopathic membranous nephropathy depending on the presence of antibodies against M-type phospholipase A2 receptor.根据抗M型磷脂酶A2受体抗体的存在情况,特发性膜性肾病的临床特征、病程及预后
Nefrologia. 2015;35(5):479-86. doi: 10.1016/j.nefro.2015.05.026. Epub 2015 Jul 7.
4
Circulating anti-phospholipase A2 receptor antibodies as a diagnostic and prognostic marker in Greek patients with idiopathic membranous nephropathy - a retrospective cohort study.循环抗磷脂酶A2受体抗体作为希腊特发性膜性肾病患者的诊断和预后标志物——一项回顾性队列研究
Rom J Intern Med. 2019 Jun 1;57(2):141-150. doi: 10.2478/rjim-2018-0044.
5
Association of serum mannose-binding lectin, anti-phospholipase A2 receptor antibody and renal outcomes in idiopathic membranous nephropathy and atypical membranous nephropathy: a single center retrospective cohort study.特发性膜性肾病和非典型膜性肾病患者血清甘露糖结合凝集素、抗磷脂酶 A2 受体抗体与肾脏结局的相关性:一项单中心回顾性队列研究。
Ren Fail. 2022 Dec;44(1):428-433. doi: 10.1080/0886022X.2022.2048016.
6
PLA2R antibody levels and clinical outcome in patients with membranous nephropathy and non-nephrotic range proteinuria under treatment with inhibitors of the renin-angiotensin system.在接受肾素-血管紧张素系统抑制剂治疗的膜性肾病和非肾病范围蛋白尿患者中,PLA2R抗体水平与临床结局
PLoS One. 2014 Oct 14;9(10):e110681. doi: 10.1371/journal.pone.0110681. eCollection 2014.
7
[Membranous nephropathy: New insights in therapeutic approach].[膜性肾病:治疗方法的新见解]
Nephrol Ther. 2017 Apr;13 Suppl 1:S83-S87. doi: 10.1016/j.nephro.2017.02.002.
8
Primary antiphospholipid syndrome associated with anti-phospholipase A2 receptor antibody-positive membranous nephropathy.原发性抗磷脂综合征伴抗磷脂酶 A2 受体抗体阳性的膜性肾病。
BMC Nephrol. 2020 May 24;21(1):196. doi: 10.1186/s12882-020-01856-z.
9
Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.特发性膜性肾病中循环抗体水平及肾沉积抗M型磷脂酶A2受体的患病率、诊断价值及临床特征
Nefrologia. 2014 May 21;34(3):353-9. doi: 10.3265/Nefrologia.pre2013.Dec.12291. Epub 2014 Feb 10.
10
Malignancy-Associated Membranous Nephropathy with Positive Anti-PLA2R Autoantibodies: Coincidence or Connection.抗磷脂酶A2受体自身抗体阳性的恶性肿瘤相关性膜性肾病:巧合还是关联?
Case Rep Nephrol Dial. 2021 Nov 18;11(3):334-339. doi: 10.1159/000520399. eCollection 2021 Sep-Dec.

本文引用的文献

1
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.利妥昔单抗或环孢素治疗膜性肾病。
N Engl J Med. 2019 Jul 4;381(1):36-46. doi: 10.1056/NEJMoa1814427.
2
A Proposal for a Serology-Based Approach to Membranous Nephropathy.一种基于血清学方法诊断膜性肾病的建议。
J Am Soc Nephrol. 2017 Feb;28(2):421-430. doi: 10.1681/ASN.2016070776. Epub 2016 Oct 24.
3
Epitope Spreading of Autoantibody Response to PLA2R Associates with Poor Prognosis in Membranous Nephropathy.抗磷脂酶A2受体自身抗体反应的表位扩展与膜性肾病的不良预后相关。
J Am Soc Nephrol. 2016 May;27(5):1517-33. doi: 10.1681/ASN.2014111061. Epub 2015 Nov 13.
4
Anti-PLA2R Antibodies as a Prognostic Factor in PLA2R-Related Membranous Nephropathy.抗磷脂酶A2受体(PLA2R)抗体作为PLA2R相关膜性肾病的一个预后因素
Am J Nephrol. 2015;42(1):70-7. doi: 10.1159/000437236. Epub 2015 Sep 5.
5
AJKD Atlas of Renal Pathology: Membranous Nephropathy.《美国肾脏病学会杂志》肾脏病理学图谱:膜性肾病
Am J Kidney Dis. 2015 Sep;66(3):e15-7. doi: 10.1053/j.ajkd.2015.07.006.
6
Anti-phospholipase A₂ receptor antibodies correlate with clinical status in idiopathic membranous nephropathy.抗磷脂酶 A₂ 受体抗体与特发性膜性肾病的临床状态相关。
Clin J Am Soc Nephrol. 2011 Jun;6(6):1286-91. doi: 10.2215/CJN.07210810. Epub 2011 Apr 7.
7
M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.M型磷脂酶A2受体作为特发性膜性肾病的靶抗原
N Engl J Med. 2009 Jul 2;361(1):11-21. doi: 10.1056/NEJMoa0810457.
8
A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy.一项关于类固醇和环磷酰胺治疗特发性膜性肾病所致成人肾病综合征的随机对照试验。
J Am Soc Nephrol. 2007 Jun;18(6):1899-904. doi: 10.1681/ASN.2007020166. Epub 2007 May 9.